Global Lacosamide Injection Market Growth 2026-2032
The global Lacosamide Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Lacosamide Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Lacosamide Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Lacosamide Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Lacosamide Injection players cover Shijiazhuang No.4 Pharmaceutical Co., Ltd., Chengdu Lier Pharmaceutical Co., Ltd., Hefei Yifan Biopharmaceuticals Inc., Jiangsu Haian Pharmaceutical Co., Ltd., Jiangxi Kerui Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Lacosamide Injection Industry Forecast” looks at past sales and reviews total world Lacosamide Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Lacosamide Injection sales for 2026 through 2032. With Lacosamide Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lacosamide Injection industry.
This Insight Report provides a comprehensive analysis of the global Lacosamide Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lacosamide Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lacosamide Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lacosamide Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lacosamide Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Lacosamide Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Lacosamide Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Lacosamide Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Lacosamide Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Lacosamide Injection players cover Shijiazhuang No.4 Pharmaceutical Co., Ltd., Chengdu Lier Pharmaceutical Co., Ltd., Hefei Yifan Biopharmaceuticals Inc., Jiangsu Haian Pharmaceutical Co., Ltd., Jiangxi Kerui Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Lacosamide Injection Industry Forecast” looks at past sales and reviews total world Lacosamide Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Lacosamide Injection sales for 2026 through 2032. With Lacosamide Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lacosamide Injection industry.
This Insight Report provides a comprehensive analysis of the global Lacosamide Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lacosamide Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lacosamide Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lacosamide Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lacosamide Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Lacosamide Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Generic Drug
- Original Drug
- Hospital
- Retail Drug Store
- Online Sales
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Shijiazhuang No.4 Pharmaceutical Co., Ltd.
- Chengdu Lier Pharmaceutical Co., Ltd.
- Hefei Yifan Biopharmaceuticals Inc.
- Jiangsu Haian Pharmaceutical Co., Ltd.
- Jiangxi Kerui Pharmaceutical Co., Ltd.
- Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
- UCB Pharma Limited
- Camber Pharmaceuticals
- Fresenius Kabi
- What is the 10-year outlook for the global Lacosamide Injection market?
- What factors are driving Lacosamide Injection market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Lacosamide Injection market opportunities vary by end market size?
- How does Lacosamide Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lacosamide Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Lacosamide Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Lacosamide Injection by Country/Region, 2021, 2025 & 2032
2.2 Lacosamide Injection Segment by Type
2.2.1 Generic Drug
2.2.2 Original Drug
2.2.3 Lacosamide Injection Sales by Type
2.2.3.1 Global Lacosamide Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Lacosamide Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Lacosamide Injection Sale Price by Type (2021-2026)
2.3 Lacosamide Injection Segment by Application
2.3.1 Hospital
2.3.2 Retail Drug Store
2.3.3 Online Sales
2.3.4 Others
2.3.5 Lacosamide Injection Sales by Application
2.3.5.1 Global Lacosamide Injection Sale Market Share by Application (2021-2026)
2.3.5.2 Global Lacosamide Injection Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Lacosamide Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Lacosamide Injection Breakdown Data by Company
3.1.1 Global Lacosamide Injection Annual Sales by Company (2021-2026)
3.1.2 Global Lacosamide Injection Sales Market Share by Company (2021-2026)
3.2 Global Lacosamide Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Lacosamide Injection Revenue by Company (2021-2026)
3.2.2 Global Lacosamide Injection Revenue Market Share by Company (2021-2026)
3.3 Global Lacosamide Injection Sale Price by Company
3.4 Key Manufacturers Lacosamide Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lacosamide Injection Product Location Distribution
3.4.2 Players Lacosamide Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LACOSAMIDE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Lacosamide Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Lacosamide Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Lacosamide Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Lacosamide Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Lacosamide Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Lacosamide Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Lacosamide Injection Sales Growth
4.4 APAC Lacosamide Injection Sales Growth
4.5 Europe Lacosamide Injection Sales Growth
4.6 Middle East & Africa Lacosamide Injection Sales Growth
5 AMERICAS
5.1 Americas Lacosamide Injection Sales by Country
5.1.1 Americas Lacosamide Injection Sales by Country (2021-2026)
5.1.2 Americas Lacosamide Injection Revenue by Country (2021-2026)
5.2 Americas Lacosamide Injection Sales by Type (2021-2026)
5.3 Americas Lacosamide Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lacosamide Injection Sales by Region
6.1.1 APAC Lacosamide Injection Sales by Region (2021-2026)
6.1.2 APAC Lacosamide Injection Revenue by Region (2021-2026)
6.2 APAC Lacosamide Injection Sales by Type (2021-2026)
6.3 APAC Lacosamide Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lacosamide Injection by Country
7.1.1 Europe Lacosamide Injection Sales by Country (2021-2026)
7.1.2 Europe Lacosamide Injection Revenue by Country (2021-2026)
7.2 Europe Lacosamide Injection Sales by Type (2021-2026)
7.3 Europe Lacosamide Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lacosamide Injection by Country
8.1.1 Middle East & Africa Lacosamide Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Lacosamide Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Lacosamide Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Lacosamide Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lacosamide Injection
10.3 Manufacturing Process Analysis of Lacosamide Injection
10.4 Industry Chain Structure of Lacosamide Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lacosamide Injection Distributors
11.3 Lacosamide Injection Customer
12 WORLD FORECAST REVIEW FOR LACOSAMIDE INJECTION BY GEOGRAPHIC REGION
12.1 Global Lacosamide Injection Market Size Forecast by Region
12.1.1 Global Lacosamide Injection Forecast by Region (2027-2032)
12.1.2 Global Lacosamide Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Lacosamide Injection Forecast by Type (2027-2032)
12.7 Global Lacosamide Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Shijiazhuang No.4 Pharmaceutical Co., Ltd.
13.1.1 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Company Information
13.1.2 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
13.1.3 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Main Business Overview
13.1.5 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Latest Developments
13.2 Chengdu Lier Pharmaceutical Co., Ltd.
13.2.1 Chengdu Lier Pharmaceutical Co., Ltd. Company Information
13.2.2 Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
13.2.3 Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Chengdu Lier Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Chengdu Lier Pharmaceutical Co., Ltd. Latest Developments
13.3 Hefei Yifan Biopharmaceuticals Inc.
13.3.1 Hefei Yifan Biopharmaceuticals Inc. Company Information
13.3.2 Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Product Portfolios and Specifications
13.3.3 Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hefei Yifan Biopharmaceuticals Inc. Main Business Overview
13.3.5 Hefei Yifan Biopharmaceuticals Inc. Latest Developments
13.4 Jiangsu Haian Pharmaceutical Co., Ltd.
13.4.1 Jiangsu Haian Pharmaceutical Co., Ltd. Company Information
13.4.2 Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
13.4.3 Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Jiangsu Haian Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Jiangsu Haian Pharmaceutical Co., Ltd. Latest Developments
13.5 Jiangxi Kerui Pharmaceutical Co., Ltd.
13.5.1 Jiangxi Kerui Pharmaceutical Co., Ltd. Company Information
13.5.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
13.5.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Jiangxi Kerui Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Jiangxi Kerui Pharmaceutical Co., Ltd. Latest Developments
13.6 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
13.6.1 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Company Information
13.6.2 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
13.6.3 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Main Business Overview
13.6.5 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Latest Developments
13.7 UCB Pharma Limited
13.7.1 UCB Pharma Limited Company Information
13.7.2 UCB Pharma Limited Lacosamide Injection Product Portfolios and Specifications
13.7.3 UCB Pharma Limited Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 UCB Pharma Limited Main Business Overview
13.7.5 UCB Pharma Limited Latest Developments
13.8 Camber Pharmaceuticals
13.8.1 Camber Pharmaceuticals Company Information
13.8.2 Camber Pharmaceuticals Lacosamide Injection Product Portfolios and Specifications
13.8.3 Camber Pharmaceuticals Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Camber Pharmaceuticals Main Business Overview
13.8.5 Camber Pharmaceuticals Latest Developments
13.9 Fresenius Kabi
13.9.1 Fresenius Kabi Company Information
13.9.2 Fresenius Kabi Lacosamide Injection Product Portfolios and Specifications
13.9.3 Fresenius Kabi Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Fresenius Kabi Main Business Overview
13.9.5 Fresenius Kabi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lacosamide Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Lacosamide Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Lacosamide Injection by Country/Region, 2021, 2025 & 2032
2.2 Lacosamide Injection Segment by Type
2.2.1 Generic Drug
2.2.2 Original Drug
2.2.3 Lacosamide Injection Sales by Type
2.2.3.1 Global Lacosamide Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Lacosamide Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Lacosamide Injection Sale Price by Type (2021-2026)
2.3 Lacosamide Injection Segment by Application
2.3.1 Hospital
2.3.2 Retail Drug Store
2.3.3 Online Sales
2.3.4 Others
2.3.5 Lacosamide Injection Sales by Application
2.3.5.1 Global Lacosamide Injection Sale Market Share by Application (2021-2026)
2.3.5.2 Global Lacosamide Injection Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Lacosamide Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Lacosamide Injection Breakdown Data by Company
3.1.1 Global Lacosamide Injection Annual Sales by Company (2021-2026)
3.1.2 Global Lacosamide Injection Sales Market Share by Company (2021-2026)
3.2 Global Lacosamide Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Lacosamide Injection Revenue by Company (2021-2026)
3.2.2 Global Lacosamide Injection Revenue Market Share by Company (2021-2026)
3.3 Global Lacosamide Injection Sale Price by Company
3.4 Key Manufacturers Lacosamide Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lacosamide Injection Product Location Distribution
3.4.2 Players Lacosamide Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LACOSAMIDE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Lacosamide Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Lacosamide Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Lacosamide Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Lacosamide Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Lacosamide Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Lacosamide Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Lacosamide Injection Sales Growth
4.4 APAC Lacosamide Injection Sales Growth
4.5 Europe Lacosamide Injection Sales Growth
4.6 Middle East & Africa Lacosamide Injection Sales Growth
5 AMERICAS
5.1 Americas Lacosamide Injection Sales by Country
5.1.1 Americas Lacosamide Injection Sales by Country (2021-2026)
5.1.2 Americas Lacosamide Injection Revenue by Country (2021-2026)
5.2 Americas Lacosamide Injection Sales by Type (2021-2026)
5.3 Americas Lacosamide Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lacosamide Injection Sales by Region
6.1.1 APAC Lacosamide Injection Sales by Region (2021-2026)
6.1.2 APAC Lacosamide Injection Revenue by Region (2021-2026)
6.2 APAC Lacosamide Injection Sales by Type (2021-2026)
6.3 APAC Lacosamide Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lacosamide Injection by Country
7.1.1 Europe Lacosamide Injection Sales by Country (2021-2026)
7.1.2 Europe Lacosamide Injection Revenue by Country (2021-2026)
7.2 Europe Lacosamide Injection Sales by Type (2021-2026)
7.3 Europe Lacosamide Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lacosamide Injection by Country
8.1.1 Middle East & Africa Lacosamide Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Lacosamide Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Lacosamide Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Lacosamide Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lacosamide Injection
10.3 Manufacturing Process Analysis of Lacosamide Injection
10.4 Industry Chain Structure of Lacosamide Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lacosamide Injection Distributors
11.3 Lacosamide Injection Customer
12 WORLD FORECAST REVIEW FOR LACOSAMIDE INJECTION BY GEOGRAPHIC REGION
12.1 Global Lacosamide Injection Market Size Forecast by Region
12.1.1 Global Lacosamide Injection Forecast by Region (2027-2032)
12.1.2 Global Lacosamide Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Lacosamide Injection Forecast by Type (2027-2032)
12.7 Global Lacosamide Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Shijiazhuang No.4 Pharmaceutical Co., Ltd.
13.1.1 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Company Information
13.1.2 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
13.1.3 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Main Business Overview
13.1.5 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Latest Developments
13.2 Chengdu Lier Pharmaceutical Co., Ltd.
13.2.1 Chengdu Lier Pharmaceutical Co., Ltd. Company Information
13.2.2 Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
13.2.3 Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Chengdu Lier Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Chengdu Lier Pharmaceutical Co., Ltd. Latest Developments
13.3 Hefei Yifan Biopharmaceuticals Inc.
13.3.1 Hefei Yifan Biopharmaceuticals Inc. Company Information
13.3.2 Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Product Portfolios and Specifications
13.3.3 Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hefei Yifan Biopharmaceuticals Inc. Main Business Overview
13.3.5 Hefei Yifan Biopharmaceuticals Inc. Latest Developments
13.4 Jiangsu Haian Pharmaceutical Co., Ltd.
13.4.1 Jiangsu Haian Pharmaceutical Co., Ltd. Company Information
13.4.2 Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
13.4.3 Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Jiangsu Haian Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Jiangsu Haian Pharmaceutical Co., Ltd. Latest Developments
13.5 Jiangxi Kerui Pharmaceutical Co., Ltd.
13.5.1 Jiangxi Kerui Pharmaceutical Co., Ltd. Company Information
13.5.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
13.5.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Jiangxi Kerui Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Jiangxi Kerui Pharmaceutical Co., Ltd. Latest Developments
13.6 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
13.6.1 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Company Information
13.6.2 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
13.6.3 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Main Business Overview
13.6.5 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Latest Developments
13.7 UCB Pharma Limited
13.7.1 UCB Pharma Limited Company Information
13.7.2 UCB Pharma Limited Lacosamide Injection Product Portfolios and Specifications
13.7.3 UCB Pharma Limited Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 UCB Pharma Limited Main Business Overview
13.7.5 UCB Pharma Limited Latest Developments
13.8 Camber Pharmaceuticals
13.8.1 Camber Pharmaceuticals Company Information
13.8.2 Camber Pharmaceuticals Lacosamide Injection Product Portfolios and Specifications
13.8.3 Camber Pharmaceuticals Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Camber Pharmaceuticals Main Business Overview
13.8.5 Camber Pharmaceuticals Latest Developments
13.9 Fresenius Kabi
13.9.1 Fresenius Kabi Company Information
13.9.2 Fresenius Kabi Lacosamide Injection Product Portfolios and Specifications
13.9.3 Fresenius Kabi Lacosamide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Fresenius Kabi Main Business Overview
13.9.5 Fresenius Kabi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Lacosamide Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Lacosamide Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Generic Drug
Table 4. Major Players of Original Drug
Table 5. Global Lacosamide Injection Sales by Type (2021-2026) & (K Boxes)
Table 6. Global Lacosamide Injection Sales Market Share by Type (2021-2026)
Table 7. Global Lacosamide Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Lacosamide Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Lacosamide Injection Sale Price by Type (2021-2026) & (US$/Box)
Table 10. Global Lacosamide Injection Sale by Application (2021-2026) & (K Boxes)
Table 11. Global Lacosamide Injection Sale Market Share by Application (2021-2026)
Table 12. Global Lacosamide Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Lacosamide Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Lacosamide Injection Sale Price by Application (2021-2026) & (US$/Box)
Table 15. Global Lacosamide Injection Sales by Company (2021-2026) & (K Boxes)
Table 16. Global Lacosamide Injection Sales Market Share by Company (2021-2026)
Table 17. Global Lacosamide Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Lacosamide Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Lacosamide Injection Sale Price by Company (2021-2026) & (US$/Box)
Table 20. Key Manufacturers Lacosamide Injection Producing Area Distribution and Sales Area
Table 21. Players Lacosamide Injection Products Offered
Table 22. Lacosamide Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Lacosamide Injection Sales by Geographic Region (2021-2026) & (K Boxes)
Table 26. Global Lacosamide Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Lacosamide Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Lacosamide Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Lacosamide Injection Sales by Country/Region (2021-2026) & (K Boxes)
Table 30. Global Lacosamide Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Lacosamide Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Lacosamide Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Lacosamide Injection Sales by Country (2021-2026) & (K Boxes)
Table 34. Americas Lacosamide Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Lacosamide Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Lacosamide Injection Sales by Type (2021-2026) & (K Boxes)
Table 37. Americas Lacosamide Injection Sales by Application (2021-2026) & (K Boxes)
Table 38. APAC Lacosamide Injection Sales by Region (2021-2026) & (K Boxes)
Table 39. APAC Lacosamide Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Lacosamide Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Lacosamide Injection Sales by Type (2021-2026) & (K Boxes)
Table 42. APAC Lacosamide Injection Sales by Application (2021-2026) & (K Boxes)
Table 43. Europe Lacosamide Injection Sales by Country (2021-2026) & (K Boxes)
Table 44. Europe Lacosamide Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Lacosamide Injection Sales by Type (2021-2026) & (K Boxes)
Table 46. Europe Lacosamide Injection Sales by Application (2021-2026) & (K Boxes)
Table 47. Middle East & Africa Lacosamide Injection Sales by Country (2021-2026) & (K Boxes)
Table 48. Middle East & Africa Lacosamide Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Lacosamide Injection Sales by Type (2021-2026) & (K Boxes)
Table 50. Middle East & Africa Lacosamide Injection Sales by Application (2021-2026) & (K Boxes)
Table 51. Key Market Drivers & Growth Opportunities of Lacosamide Injection
Table 52. Key Market Challenges & Risks of Lacosamide Injection
Table 53. Key Industry Trends of Lacosamide Injection
Table 54. Lacosamide Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Lacosamide Injection Distributors List
Table 57. Lacosamide Injection Customer List
Table 58. Global Lacosamide Injection Sales Forecast by Region (2027-2032) & (K Boxes)
Table 59. Global Lacosamide Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Lacosamide Injection Sales Forecast by Country (2027-2032) & (K Boxes)
Table 61. Americas Lacosamide Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Lacosamide Injection Sales Forecast by Region (2027-2032) & (K Boxes)
Table 63. APAC Lacosamide Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Lacosamide Injection Sales Forecast by Country (2027-2032) & (K Boxes)
Table 65. Europe Lacosamide Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Lacosamide Injection Sales Forecast by Country (2027-2032) & (K Boxes)
Table 67. Middle East & Africa Lacosamide Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Lacosamide Injection Sales Forecast by Type (2027-2032) & (K Boxes)
Table 69. Global Lacosamide Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Lacosamide Injection Sales Forecast by Application (2027-2032) & (K Boxes)
Table 71. Global Lacosamide Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
Table 74. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 75. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Main Business
Table 76. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Latest Developments
Table 77. Chengdu Lier Pharmaceutical Co., Ltd. Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
Table 79. Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 80. Chengdu Lier Pharmaceutical Co., Ltd. Main Business
Table 81. Chengdu Lier Pharmaceutical Co., Ltd. Latest Developments
Table 82. Hefei Yifan Biopharmaceuticals Inc. Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Product Portfolios and Specifications
Table 84. Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 85. Hefei Yifan Biopharmaceuticals Inc. Main Business
Table 86. Hefei Yifan Biopharmaceuticals Inc. Latest Developments
Table 87. Jiangsu Haian Pharmaceutical Co., Ltd. Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
Table 89. Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 90. Jiangsu Haian Pharmaceutical Co., Ltd. Main Business
Table 91. Jiangsu Haian Pharmaceutical Co., Ltd. Latest Developments
Table 92. Jiangxi Kerui Pharmaceutical Co., Ltd. Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
Table 94. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 95. Jiangxi Kerui Pharmaceutical Co., Ltd. Main Business
Table 96. Jiangxi Kerui Pharmaceutical Co., Ltd. Latest Developments
Table 97. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
Table 99. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 100. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Main Business
Table 101. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Latest Developments
Table 102. UCB Pharma Limited Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. UCB Pharma Limited Lacosamide Injection Product Portfolios and Specifications
Table 104. UCB Pharma Limited Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 105. UCB Pharma Limited Main Business
Table 106. UCB Pharma Limited Latest Developments
Table 107. Camber Pharmaceuticals Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Camber Pharmaceuticals Lacosamide Injection Product Portfolios and Specifications
Table 109. Camber Pharmaceuticals Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 110. Camber Pharmaceuticals Main Business
Table 111. Camber Pharmaceuticals Latest Developments
Table 112. Fresenius Kabi Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Fresenius Kabi Lacosamide Injection Product Portfolios and Specifications
Table 114. Fresenius Kabi Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 115. Fresenius Kabi Main Business
Table 116. Fresenius Kabi Latest Developments
Table 1. Lacosamide Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Lacosamide Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Generic Drug
Table 4. Major Players of Original Drug
Table 5. Global Lacosamide Injection Sales by Type (2021-2026) & (K Boxes)
Table 6. Global Lacosamide Injection Sales Market Share by Type (2021-2026)
Table 7. Global Lacosamide Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Lacosamide Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Lacosamide Injection Sale Price by Type (2021-2026) & (US$/Box)
Table 10. Global Lacosamide Injection Sale by Application (2021-2026) & (K Boxes)
Table 11. Global Lacosamide Injection Sale Market Share by Application (2021-2026)
Table 12. Global Lacosamide Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Lacosamide Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Lacosamide Injection Sale Price by Application (2021-2026) & (US$/Box)
Table 15. Global Lacosamide Injection Sales by Company (2021-2026) & (K Boxes)
Table 16. Global Lacosamide Injection Sales Market Share by Company (2021-2026)
Table 17. Global Lacosamide Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Lacosamide Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Lacosamide Injection Sale Price by Company (2021-2026) & (US$/Box)
Table 20. Key Manufacturers Lacosamide Injection Producing Area Distribution and Sales Area
Table 21. Players Lacosamide Injection Products Offered
Table 22. Lacosamide Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Lacosamide Injection Sales by Geographic Region (2021-2026) & (K Boxes)
Table 26. Global Lacosamide Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Lacosamide Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Lacosamide Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Lacosamide Injection Sales by Country/Region (2021-2026) & (K Boxes)
Table 30. Global Lacosamide Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Lacosamide Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Lacosamide Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Lacosamide Injection Sales by Country (2021-2026) & (K Boxes)
Table 34. Americas Lacosamide Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Lacosamide Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Lacosamide Injection Sales by Type (2021-2026) & (K Boxes)
Table 37. Americas Lacosamide Injection Sales by Application (2021-2026) & (K Boxes)
Table 38. APAC Lacosamide Injection Sales by Region (2021-2026) & (K Boxes)
Table 39. APAC Lacosamide Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Lacosamide Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Lacosamide Injection Sales by Type (2021-2026) & (K Boxes)
Table 42. APAC Lacosamide Injection Sales by Application (2021-2026) & (K Boxes)
Table 43. Europe Lacosamide Injection Sales by Country (2021-2026) & (K Boxes)
Table 44. Europe Lacosamide Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Lacosamide Injection Sales by Type (2021-2026) & (K Boxes)
Table 46. Europe Lacosamide Injection Sales by Application (2021-2026) & (K Boxes)
Table 47. Middle East & Africa Lacosamide Injection Sales by Country (2021-2026) & (K Boxes)
Table 48. Middle East & Africa Lacosamide Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Lacosamide Injection Sales by Type (2021-2026) & (K Boxes)
Table 50. Middle East & Africa Lacosamide Injection Sales by Application (2021-2026) & (K Boxes)
Table 51. Key Market Drivers & Growth Opportunities of Lacosamide Injection
Table 52. Key Market Challenges & Risks of Lacosamide Injection
Table 53. Key Industry Trends of Lacosamide Injection
Table 54. Lacosamide Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Lacosamide Injection Distributors List
Table 57. Lacosamide Injection Customer List
Table 58. Global Lacosamide Injection Sales Forecast by Region (2027-2032) & (K Boxes)
Table 59. Global Lacosamide Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Lacosamide Injection Sales Forecast by Country (2027-2032) & (K Boxes)
Table 61. Americas Lacosamide Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Lacosamide Injection Sales Forecast by Region (2027-2032) & (K Boxes)
Table 63. APAC Lacosamide Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Lacosamide Injection Sales Forecast by Country (2027-2032) & (K Boxes)
Table 65. Europe Lacosamide Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Lacosamide Injection Sales Forecast by Country (2027-2032) & (K Boxes)
Table 67. Middle East & Africa Lacosamide Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Lacosamide Injection Sales Forecast by Type (2027-2032) & (K Boxes)
Table 69. Global Lacosamide Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Lacosamide Injection Sales Forecast by Application (2027-2032) & (K Boxes)
Table 71. Global Lacosamide Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
Table 74. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 75. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Main Business
Table 76. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Latest Developments
Table 77. Chengdu Lier Pharmaceutical Co., Ltd. Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
Table 79. Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 80. Chengdu Lier Pharmaceutical Co., Ltd. Main Business
Table 81. Chengdu Lier Pharmaceutical Co., Ltd. Latest Developments
Table 82. Hefei Yifan Biopharmaceuticals Inc. Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Product Portfolios and Specifications
Table 84. Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 85. Hefei Yifan Biopharmaceuticals Inc. Main Business
Table 86. Hefei Yifan Biopharmaceuticals Inc. Latest Developments
Table 87. Jiangsu Haian Pharmaceutical Co., Ltd. Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
Table 89. Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 90. Jiangsu Haian Pharmaceutical Co., Ltd. Main Business
Table 91. Jiangsu Haian Pharmaceutical Co., Ltd. Latest Developments
Table 92. Jiangxi Kerui Pharmaceutical Co., Ltd. Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
Table 94. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 95. Jiangxi Kerui Pharmaceutical Co., Ltd. Main Business
Table 96. Jiangxi Kerui Pharmaceutical Co., Ltd. Latest Developments
Table 97. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Product Portfolios and Specifications
Table 99. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 100. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Main Business
Table 101. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Latest Developments
Table 102. UCB Pharma Limited Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. UCB Pharma Limited Lacosamide Injection Product Portfolios and Specifications
Table 104. UCB Pharma Limited Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 105. UCB Pharma Limited Main Business
Table 106. UCB Pharma Limited Latest Developments
Table 107. Camber Pharmaceuticals Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Camber Pharmaceuticals Lacosamide Injection Product Portfolios and Specifications
Table 109. Camber Pharmaceuticals Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 110. Camber Pharmaceuticals Main Business
Table 111. Camber Pharmaceuticals Latest Developments
Table 112. Fresenius Kabi Basic Information, Lacosamide Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Fresenius Kabi Lacosamide Injection Product Portfolios and Specifications
Table 114. Fresenius Kabi Lacosamide Injection Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2021-2026)
Table 115. Fresenius Kabi Main Business
Table 116. Fresenius Kabi Latest Developments
LIST OF FIGURES
Figure 1. Picture of Lacosamide Injection
Figure 2. Lacosamide Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lacosamide Injection Sales Growth Rate 2021-2032 (K Boxes)
Figure 7. Global Lacosamide Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Lacosamide Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Lacosamide Injection Sales Market Share by Country/Region (2025)
Figure 10. Lacosamide Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Generic Drug
Figure 12. Product Picture of Original Drug
Figure 13. Global Lacosamide Injection Sales Market Share by Type in 2026
Figure 14. Global Lacosamide Injection Revenue Market Share by Type (2021-2026)
Figure 15. Lacosamide Injection Consumed in Hospital
Figure 16. Global Lacosamide Injection Market: Hospital (2021-2026) & (K Boxes)
Figure 17. Lacosamide Injection Consumed in Retail Drug Store
Figure 18. Global Lacosamide Injection Market: Retail Drug Store (2021-2026) & (K Boxes)
Figure 19. Lacosamide Injection Consumed in Online Sales
Figure 20. Global Lacosamide Injection Market: Online Sales (2021-2026) & (K Boxes)
Figure 21. Lacosamide Injection Consumed in Others
Figure 22. Global Lacosamide Injection Market: Others (2021-2026) & (K Boxes)
Figure 23. Global Lacosamide Injection Sale Market Share by Application (2025)
Figure 24. Global Lacosamide Injection Revenue Market Share by Application in 2026
Figure 25. Lacosamide Injection Sales by Company in 2026 (K Boxes)
Figure 26. Global Lacosamide Injection Sales Market Share by Company in 2026
Figure 27. Lacosamide Injection Revenue by Company in 2026 ($ millions)
Figure 28. Global Lacosamide Injection Revenue Market Share by Company in 2026
Figure 29. Global Lacosamide Injection Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Lacosamide Injection Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Lacosamide Injection Sales 2021-2026 (K Boxes)
Figure 32. Americas Lacosamide Injection Revenue 2021-2026 ($ millions)
Figure 33. APAC Lacosamide Injection Sales 2021-2026 (K Boxes)
Figure 34. APAC Lacosamide Injection Revenue 2021-2026 ($ millions)
Figure 35. Europe Lacosamide Injection Sales 2021-2026 (K Boxes)
Figure 36. Europe Lacosamide Injection Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Lacosamide Injection Sales 2021-2026 (K Boxes)
Figure 38. Middle East & Africa Lacosamide Injection Revenue 2021-2026 ($ millions)
Figure 39. Americas Lacosamide Injection Sales Market Share by Country in 2026
Figure 40. Americas Lacosamide Injection Revenue Market Share by Country (2021-2026)
Figure 41. Americas Lacosamide Injection Sales Market Share by Type (2021-2026)
Figure 42. Americas Lacosamide Injection Sales Market Share by Application (2021-2026)
Figure 43. United States Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Lacosamide Injection Sales Market Share by Region in 2026
Figure 48. APAC Lacosamide Injection Revenue Market Share by Region (2021-2026)
Figure 49. APAC Lacosamide Injection Sales Market Share by Type (2021-2026)
Figure 50. APAC Lacosamide Injection Sales Market Share by Application (2021-2026)
Figure 51. China Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. India Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Lacosamide Injection Sales Market Share by Country in 2026
Figure 59. Europe Lacosamide Injection Revenue Market Share by Country (2021-2026)
Figure 60. Europe Lacosamide Injection Sales Market Share by Type (2021-2026)
Figure 61. Europe Lacosamide Injection Sales Market Share by Application (2021-2026)
Figure 62. Germany Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. France Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Lacosamide Injection Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Lacosamide Injection Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Lacosamide Injection Sales Market Share by Application (2021-2026)
Figure 70. Egypt Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Lacosamide Injection in 2026
Figure 76. Manufacturing Process Analysis of Lacosamide Injection
Figure 77. Industry Chain Structure of Lacosamide Injection
Figure 78. Channels of Distribution
Figure 79. Global Lacosamide Injection Sales Market Forecast by Region (2027-2032)
Figure 80. Global Lacosamide Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Lacosamide Injection Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Lacosamide Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Lacosamide Injection Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Lacosamide Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Lacosamide Injection
Figure 2. Lacosamide Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lacosamide Injection Sales Growth Rate 2021-2032 (K Boxes)
Figure 7. Global Lacosamide Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Lacosamide Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Lacosamide Injection Sales Market Share by Country/Region (2025)
Figure 10. Lacosamide Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Generic Drug
Figure 12. Product Picture of Original Drug
Figure 13. Global Lacosamide Injection Sales Market Share by Type in 2026
Figure 14. Global Lacosamide Injection Revenue Market Share by Type (2021-2026)
Figure 15. Lacosamide Injection Consumed in Hospital
Figure 16. Global Lacosamide Injection Market: Hospital (2021-2026) & (K Boxes)
Figure 17. Lacosamide Injection Consumed in Retail Drug Store
Figure 18. Global Lacosamide Injection Market: Retail Drug Store (2021-2026) & (K Boxes)
Figure 19. Lacosamide Injection Consumed in Online Sales
Figure 20. Global Lacosamide Injection Market: Online Sales (2021-2026) & (K Boxes)
Figure 21. Lacosamide Injection Consumed in Others
Figure 22. Global Lacosamide Injection Market: Others (2021-2026) & (K Boxes)
Figure 23. Global Lacosamide Injection Sale Market Share by Application (2025)
Figure 24. Global Lacosamide Injection Revenue Market Share by Application in 2026
Figure 25. Lacosamide Injection Sales by Company in 2026 (K Boxes)
Figure 26. Global Lacosamide Injection Sales Market Share by Company in 2026
Figure 27. Lacosamide Injection Revenue by Company in 2026 ($ millions)
Figure 28. Global Lacosamide Injection Revenue Market Share by Company in 2026
Figure 29. Global Lacosamide Injection Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Lacosamide Injection Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Lacosamide Injection Sales 2021-2026 (K Boxes)
Figure 32. Americas Lacosamide Injection Revenue 2021-2026 ($ millions)
Figure 33. APAC Lacosamide Injection Sales 2021-2026 (K Boxes)
Figure 34. APAC Lacosamide Injection Revenue 2021-2026 ($ millions)
Figure 35. Europe Lacosamide Injection Sales 2021-2026 (K Boxes)
Figure 36. Europe Lacosamide Injection Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Lacosamide Injection Sales 2021-2026 (K Boxes)
Figure 38. Middle East & Africa Lacosamide Injection Revenue 2021-2026 ($ millions)
Figure 39. Americas Lacosamide Injection Sales Market Share by Country in 2026
Figure 40. Americas Lacosamide Injection Revenue Market Share by Country (2021-2026)
Figure 41. Americas Lacosamide Injection Sales Market Share by Type (2021-2026)
Figure 42. Americas Lacosamide Injection Sales Market Share by Application (2021-2026)
Figure 43. United States Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Lacosamide Injection Sales Market Share by Region in 2026
Figure 48. APAC Lacosamide Injection Revenue Market Share by Region (2021-2026)
Figure 49. APAC Lacosamide Injection Sales Market Share by Type (2021-2026)
Figure 50. APAC Lacosamide Injection Sales Market Share by Application (2021-2026)
Figure 51. China Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. India Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Lacosamide Injection Sales Market Share by Country in 2026
Figure 59. Europe Lacosamide Injection Revenue Market Share by Country (2021-2026)
Figure 60. Europe Lacosamide Injection Sales Market Share by Type (2021-2026)
Figure 61. Europe Lacosamide Injection Sales Market Share by Application (2021-2026)
Figure 62. Germany Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. France Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Lacosamide Injection Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Lacosamide Injection Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Lacosamide Injection Sales Market Share by Application (2021-2026)
Figure 70. Egypt Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Lacosamide Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Lacosamide Injection in 2026
Figure 76. Manufacturing Process Analysis of Lacosamide Injection
Figure 77. Industry Chain Structure of Lacosamide Injection
Figure 78. Channels of Distribution
Figure 79. Global Lacosamide Injection Sales Market Forecast by Region (2027-2032)
Figure 80. Global Lacosamide Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Lacosamide Injection Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Lacosamide Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Lacosamide Injection Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Lacosamide Injection Revenue Market Share Forecast by Application (2027-2032)
